Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 9/20 | 0.40 |
| ▸ | HTR2B | P41595 | 8/20 | 0.39 |
| ▸ | HTR7 | P34969 | 7/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7830859 | 0.93 | SLC9A1 (0.46) | SLC9A1 | |
| SCHEMBL7830864 | 0.82 | SLC9A1 (0.34) | SLC9A1 | |
| SCHEMBL7918344 | 0.80 | SLC9A1 (0.47) | SLC9A1HTR2BHTR7DRD2ADRA1D | |
| SCHEMBL8804547 | 0.79 | HTR2B (0.43) | SLC9A1HTR2BHTR7DRD2ADRA1D | |
| SCHEMBL8803085 | 0.79 | BCAT2 (0.44) | SLC9A1HTR2BHTR7DRD2ADRA1D | |
| SCHEMBL8703714 | 0.78 | MEN1 (0.35) | — | |
| SCHEMBL1387961 | 0.78 | SLC9A1 (0.48) | SLC9A1HTR2BHTR7DRD2ADRA1D | |
| SCHEMBL7823119 | 0.77 | PLAU (0.44) | — | |
| Hydrochloric Acid SCHEMBL7830172 | 0.77 | HTR2B (0.49) | SLC9A1HTR2BHTR7DRD2ADRA1D | |
| SCHEMBL8803739 | 0.76 | SLC9A1 (0.52) | SLC9A1HTR2BHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1080257-C | Guanidine derivatives as inhibitors of Na+/H+ exchange in cells | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-03-06 | — | — | CN | claimed |
| EP-0699185-B1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-09-05 | — | — | EP | claimed |
| US-5824691-A | CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-20 | — | — | US | claimed |
| JP-H08511243-A | — | — | 1996-11-26 | — | — | JP | claimed |
| CN-1123545-A | Guanidine derivatives as inhibitors of Na+/H+ exchange in cells | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-05-29 | — | — | CN | claimed |
| EP-0699185-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-03-06 | — | — | EP | claimed |
| WO-1994026709-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-24 | — | — | WO | claimed |
| WO-1994026709-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-24 | — | — | WO | disclosed |